News
MEDP
372.00
-0.62%
-2.32
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
NASDAQ · 1d ago
Weekly Report: what happened at MEDP last week (0408-0412)?
Weekly Report · 4d ago
Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Medpace Holdings has grown its earnings per share by 31% per year over three years. The company has grown revenue by 29% to US$1.9b. Medpace Holdings's CEO pay is modest compared to other companies with similar size. Insiders hold 18% of the company and have a large stake in the company. The stock has grown at a rate of 31% over the past year. Medspace Holdings is worth keeping an eye on but it may appeal to more investors.
Simply Wall St · 04/12 10:48
Vulcan Value Partners Q1 2024 Letter
Vulcan Value Partners are value investors with a long-term time horizon. All strategy composites produced positive returns during the first quarter of 2024. The fund is focused on buying companies that are competitively entrenched at significant discounts to intrinsic worth. The company is generally pleased with its performance in 2024.
Seeking Alpha · 04/10 15:35
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
NASDAQ · 04/09 18:24
ClearBridge Small Cap Growth Strategy Q2 2024 Portfolio Manager Commentary
Seeking Alpha · 04/09 15:00
Notable ETF Inflow Detected - XMHQ, MANH, CELH, MEDP
NASDAQ · 04/09 14:55
Why You Should Add Ensign Group (ENSG) to Your Portfolio Now
NASDAQ · 04/08 17:56
Weekly Report: what happened at MEDP last week (0401-0405)?
Weekly Report · 04/08 09:14
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
NASDAQ · 04/05 16:10
S&P 500 Futures Fall In Premarket Trading; On Holding, Blue Owl Capital Lead
U.S. Stock markets set to open in two hours. On Holding AG was up 5.7% in pre-market trading. S&P 500 futures were down 0.13% in early trading. Brent crude oil futures were up 0.84%. Bitcoin fell 0.32% to $65,872. Stocks in Asia were down overnight.
Barron‘s · 04/03 11:31
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
NASDAQ · 04/02 16:58
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,500 Today
Medpace Hldgs has outperformed the market over the past 5 years by 33.11%. The company has an average annual return of 45.48%. If an investor bought $1000 of MEDP stock 5 years ago, it would be worth $6,523.83 today.
Benzinga · 04/02 14:00
Weekly Report: what happened at MEDP last week (0325-0329)?
Weekly Report · 04/01 09:14
12 Health Care Stocks Moving In Friday's After-Market Session
Qilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. Sunshine Biopharma stock moved upwards by 39.5% as the company's market cap rose to $8.3 million. Xilio Therapeutics and Medpace Hldgs also rose in the wake of Q4 earnings.
Benzinga · 03/29 20:30
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
NASDAQ · 03/29 10:20
Sharecare, Inc. (SHCR) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/28 21:45
Press Release: Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
Medpace Holdings, Inc. To Report First Quarter 2024 Financial Results on April 22, 2024. The Company will host a conference call the following morning, April 23, 2024, at 9:00 a.m. ET to discuss these results. Medpace will report its first quarter 2024 financial results after the market close on Monday, April 22.
Dow Jones · 03/28 20:28
Reasons to Add Cencora (COR) Stock in Your Portfolio Now
NASDAQ · 03/27 11:19
Medpace Holdings (NASDAQ:MEDP) stock performs better than its underlying earnings growth over last five years
Medpace Holdings, Inc. Shares have gained 564% in the last five years. The company has managed to grow its earnings per share at 35% a year. Medpace Holdings has a total shareholder return of 122% over the last 12 months. It's worth looking at the company's earnings growth over the longer term.
Simply Wall St · 03/27 10:12
More
Webull provides a variety of real-time MEDP stock news. You can receive the latest news about Medpace Holdings through multiple platforms. This information may help you make smarter investment decisions.
About MEDP
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.